Eurobio Scientific S.A. (ALERS.PA) Stock Analysis & Winston Score
Eurobio Scientific is a French company that makes and sells medical diagnostic tools. Its products help doctors and laboratories detect diseases, monitor organ transplants, and run tests on blood and other samples. The company sells mainly to hospitals, clinical labs, and research centers across Europe. Eurobio Scientific makes money by selling diagnostic kits, reagents, and laboratory equipment directly to healthcare customers. It operates primarily in France and other European markets, and it also distributes products from other manufacturers, which adds a second revenue stream alongside its own branded goods. The company is relatively small, with a market cap around $200 million, and its competitive position relies on specialized expertise in transplant diagnostics and infectious disease testing. A key risk is its dependence on a limited number of product lines and geographic markets, which leaves it exposed if larger global diagnostics companies increase competition or if hospital procurement budgets tighten.
Winston Score: 55/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Mixed (12/30)
- Growth: Mixed (9/20)
- Cash Flow: Strong (7/10)
- Stability: Strong (8/10)
- Valuation: Good (6/10)
- Ownership: Good (10/15)
Key Facts
Price: €19.90
Market Cap: €200M
Sector: Healthcare
Industry: Medical - Devices
Exchange: Euronext Paris

